Advertisement

Topics

CVD REAL: Primary Prevention for SGLT-2 Inhibitors in Diabetes?

05:37 EDT 20 Jun 2017 | Medscape

The CVD REAL study hints that patients with diabetes, even without existing cardiovascular disease, could benefit from this drug class, but some question the survival benefit seen in such a brief time.
Medscape Medical News

Original Article: CVD REAL: Primary Prevention for SGLT-2 Inhibitors in Diabetes?

NEXT ARTICLE

More From BioPortfolio on "CVD REAL: Primary Prevention for SGLT-2 Inhibitors in Diabetes?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...